Afatinib versus methotrexate as second-line treatment for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) progressing on or after plat... von Guo, Ye, Ahn, Myung-Ju, Chan, Anthony T. C., Wang, Cheng-Hsu, Kang, Jin Hyoung, Kim, Sung-Bae, Bello, Maximino De Guzman, Singh Arora, Rajendra, Zhang, Qingyuan, He, Xiaohui, Li, Ping, Dechaphunkul, Arunee, Kumar, Vijay, Kamble, Krishna, Li, Wei, Kandil, Alaa, Cohen, Ezra E.W., Geng, Yuan, Zografos, Lef, Tang, Ping Zhang

Volltext

A randomized, double-blind, phase III study comparing SB3 (trastuzumab biosimilar) with originator trastuzumab in patients treated by neoadjuvant therapy for HER2-positive early br... von Pivot, Xavier B., Bondarenko, Igor, Dvorkin, Mikhail, Trishkina, Ekaterina, Ahn, Jin-Hee, Im, Seock-Ah, Sarosiek, Tomasz, Chattopadhyay, Sanjay, Wojtukiewicz, Marek, Moiseyenko, Vladimir, Shparyk, Yaroslav V., Bello, Maximino De Guzman, Semiglazov, Vladimir, Song, Sujeong, Lim, Jae Yun

Volltext